Searchable abstracts of presentations at key conferences in endocrinology

ea0014oc6.1 | Cardiovascular endocrinology | ECE2007

Growth hormone-releasing hormone prevents cardiomyocyte apoptosis and activated PI3K/AKT, ERK1/2 and CREB signaling pathways

Granata Riccarda , Trovato Letizia , Destefanis Silvia , Settanni Fabio , Annunziata Marta , Gallo Davide , Ghigo Ezio

The hypothalamic hormone growth hormone-releasing hormone (GHRH), has been shown to function via its receptor splice variants as an autocrine/paracrine growth factor in normal and malignant cell lines and tissues, besides positively regulating growth hormone (GH) synthesis and secretion from the pituitary. Moreover, GHRH antagonists are known to suppress the proliferation of a wide variety of cancer cells through mechanisms yet to be fully elucidated. Aim of this study was to ...

ea0016p611 | Reproduction | ECE2008

Endometriotic cell proliferation and survival are inhibited by somatostatin analogues and GHRH antagonists

Annunziata Marta , Trovato Letizia , Settanni Fabio , Grande Cristina , Gallo Davide , Camanni Marco , Deltetto Francesco , Ghigo Ezio , Granata Riccarda

Somatostatin (SST) and growth hormone-releasing hormone (GHRH) are hypothalamic hormones that, respectively, inhibit and stimulate pituitary GH secretion. In addition, in peripheral tissues somatostatin and its analogues inhibit, whereas GHRH stimulates, both normal and cancer cell growth and survival. Furthermore, both somatostatin receptor 2 (SSTR-2) and GHRH expression have been shown in normal human endometrium. Endometriosis is a common estrogen-dependent disorder defined...